The pharmaceutical company Natco Pharma Ltd. from India – is one of the largest players in the global pharmaceutical market. Natco Pharma is widely known in many countries due to large-scale advances in innovation, pharmacological research and the production of medicines. Natco is the first to receive a license for the production and distribution in many developing countries of a generic drug for the treatment of Hepatitis C (Sofosbuvir), and a new combination drug for the treatment of genotype 1 and 4 of Hepatitis C (Sofosbuvir 400 mg / Ladipasvir 90 mg) Under its own trademark Hepcinat-LP. And another Natco begins production of the drug Daclatasvir under the Natdac brand.
List of Active Pharmaceutical Ingredients (APIs) manufactured by NATCO PHARMA LIMITED include.
- 1. “Hepcinat LP” Contents “Ledipasvir and Sofosbuvir”;
- 2. “Natdac” Content “Daclatasvir 60 mg“;
- 3. “Hepcinat” Content “Sofosbuvir 400mg” .
Read full information : https://pharmaceutical-supplier.blogspot.in